93 related articles for article (PubMed ID: 17662106)
1. Immunonanoparticles--an effective tool to impair harmful proteolysis in invasive breast tumor cells.
Obermajer N; Kocbek P; Repnik U; Kuznik A; Cegnar M; Kristl J; Kos J
FEBS J; 2007 Sep; 274(17):4416-27. PubMed ID: 17662106
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of harmful tumour-associated proteolysis by nanoparticulate system.
Kos J; Obermajer N; Doljak B; Kocbek P; Kristl J
Int J Pharm; 2009 Nov; 381(2):106-12. PubMed ID: 19422896
[TBL] [Abstract][Full Text] [Related]
3. Poly(lactide-co-glycolide) nanoparticles as a carrier system for delivering cysteine protease inhibitor cystatin into tumor cells.
Cegnar M; Premzl A; Zavasnik-Bergant V; Kristl J; Kos J
Exp Cell Res; 2004 Dec; 301(2):223-31. PubMed ID: 15530858
[TBL] [Abstract][Full Text] [Related]
4. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity.
Coopman PJ; Do MT; Thompson EW; Mueller SC
Clin Cancer Res; 1998 Feb; 4(2):507-15. PubMed ID: 9516943
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the sugarcane cystatin CaneCPI-4 on cathepsins B and L and human breast cancer cell invasion.
Gianotti A; Sommer CA; Carmona AK; Henrique-Silva F
Biol Chem; 2008 Apr; 389(4):447-53. PubMed ID: 18208350
[TBL] [Abstract][Full Text] [Related]
6. Proteinase activity in invasive cancer of the breast. Correlation with tumor progression.
Benítez-Bribiesca L; Martínez G; Ruíz MT; Gutiérrez-Delgado F; Utrera D
Arch Med Res; 1995; 26 Spec No():S163-8. PubMed ID: 8845643
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment.
Laurent-Matha V; Huesgen PF; Masson O; Derocq D; Prébois C; Gary-Bobo M; Lecaille F; Rebière B; Meurice G; Oréar C; Hollingsworth RE; Abrahamson M; Lalmanach G; Overall CM; Liaudet-Coopman E
FASEB J; 2012 Dec; 26(12):5172-81. PubMed ID: 22898924
[TBL] [Abstract][Full Text] [Related]
8. [The role of proteolytic enzymes in skin neoplasm progression and development of metastasis].
Kozłowski L; Wojtukiewicz MZ
Postepy Hig Med Dosw; 1999; 53(6):841-54. PubMed ID: 10737043
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin D in the malignant progression of neoplastic diseases (review).
Leto G; Gebbia N; Rausa L; Tumminello FM
Anticancer Res; 1992; 12(1):235-40. PubMed ID: 1567172
[TBL] [Abstract][Full Text] [Related]
10. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
11. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
[TBL] [Abstract][Full Text] [Related]
12. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
[TBL] [Abstract][Full Text] [Related]
13. CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.
Peng ST; Su CH; Kuo CC; Shaw CF; Wang HS
Int J Oncol; 2007 Nov; 31(5):1119-26. PubMed ID: 17912438
[TBL] [Abstract][Full Text] [Related]
14. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
15. Functional measurement of local proteolytic activity in living cells of invasive and non-invasive tumors.
Ludwig T; Püttmann S; Bertram H; Tatenhorst L; Paulus W; Oberleithner H; Senner V
J Cell Physiol; 2005 Mar; 202(3):690-7. PubMed ID: 15389570
[TBL] [Abstract][Full Text] [Related]
16. Antiproteases in preventing the invasive potential of pancreatic cancer cells.
Takahashi H; Sawai H; Funahashi H; Matsuo Y; Yasuda A; Ochi N; Sato M; Okada Y; Takeyama H
JOP; 2007 Jul; 8(4 Suppl):501-8. PubMed ID: 17625307
[TBL] [Abstract][Full Text] [Related]
17. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
Lizárraga F; Poincloux R; Romao M; Montagnac G; Le Dez G; Bonne I; Rigaill G; Raposo G; Chavrier P
Cancer Res; 2009 Apr; 69(7):2792-800. PubMed ID: 19276357
[TBL] [Abstract][Full Text] [Related]
18. Acid-mediated tumor invasion: a multidisciplinary study.
Gatenby RA; Gawlinski ET; Gmitro AF; Kaylor B; Gillies RJ
Cancer Res; 2006 May; 66(10):5216-23. PubMed ID: 16707446
[TBL] [Abstract][Full Text] [Related]
19. [The presence of large acidic vesicles is correlated with in vitro invasive potential of breast cancer cells].
Montcourrier P; Valembois C; Rochefort H
C R Acad Sci III; 1993; 316(4):421-4. PubMed ID: 8402270
[TBL] [Abstract][Full Text] [Related]
20. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
